Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 001540342 approvals65 trials

AHN-GOOK PHARMACEUTICAL Co., Ltd.

Official website

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1959, Ahn-Gook Pharmaceutical listed on KOSDAQ in 2000 as a pharmaceutical and health functional food company. It sells the cough/expectorant drug Sinecuran along with Febarozet, Levotension, and Shubazet for the circulatory and respiratory markets, plus the eye-health supplement Tobicom, and diversifies distribution through its online channel 'A-Wonder'. It operates a GMP-certified plant in Hyangnam-eup, Hwaseong, alongside a CMO business, expanded its R&D center to a new Gwacheon headquarters in 2024, and posted consolidated 2025 sales of KRW 306.874 billion (up 13.2% YoY), with Sinecuran and Febarozet accounting for 10.5% and 8.7% of sales respectively.

Products & technology

  • SinecuranCough/expectorant drug
  • FebarozetCirculatory system drug
  • LevotensionCirculatory system drug
  • Shubazet
  • TobicomEye-health supplement

Regulatory approvals

data.go.kr

340 Korean MFDS drug approvals · 1970–2026 / 2 Korean MFDS device approvals · 2009–2014

  • MFDS drugPenorexin cap.2026-06-25
    Drug · Prescription · Approval202601808
  • MFDS drugDoneduo Tab. 10/20mg2026-05-13
    Drug · Prescription · Approval202601402
  • MFDS drugLevosartan Plus tab. 2.5/160/2.5mg2026-04-28
    Drug · Prescription · Approval202601268
  • MFDS drugLevosartan Plus tab. 2.5/160/1.25mg2026-04-28
    Drug · Prescription · Approval202601269
  • MFDS drugLevosartan Plus tab. 2.5/80/1.25mg2026-04-28
    Drug · Prescription · Approval202601270
  • MFDS drugPevarozet Tab. 1/10mg2026-04-20
    Drug · Prescription · Approval202601147
  • MFDS drugVonopack Tab. 10mg2026-03-06
    Drug · Prescription · Approval202600668
  • MFDS drugVonopack Tab. 20mg2026-03-06
    Drug · Prescription · Approval202600669
  • MFDS drugVitus Tab. 50mg2026-01-19
    Drug · Prescription · Approval202600162
  • MFDS drugCalmbreat Suspension for Nebulizer2026-01-16
    Drug · Prescription · Approval202600155
  • MFDS drugAlphasidol Soft Cap.0.5μg2025-12-01
    Drug · OTC · Notification202503126
  • MFDS drugPevaro F Tab.2025-08-29
    Drug · Prescription · Approval202502269
Show 68 more
  • MFDS drugCiustar Tab. 2.5mg2025-06-12
    Drug · Prescription · Approval202501436
  • MFDS drugDonetia Powd. 5mg, Donetia Powd. 10mg2025-05-30
    Drug · Prescription · Approval202501347
  • MFDS drugDiQvan Tab. 40mg2025-03-27
    Drug · Prescription · Approval202500724
  • MFDS drugBromtella Eye drops2024-11-04
    Drug · Prescription · Approval202402584
  • MFDS drugAvusmet Tab. 50/1000mg2024-05-24
    Drug · Prescription · Approval202401283
  • MFDS drugA-Duta Soft Cap. 0.5mg2024-04-04
    Drug · Prescription · Approval202400769
  • MFDS drugKano N Tab. 30mg2024-02-29
    Drug · Prescription · Approval202400426
  • MFDS drugOlotella eye drops. 0.2%2024-01-29
    Drug · Prescription · Approval202400217
  • MFDS drugA-diance Duo Tab. 12.5/500mg2023-08-30
    Drug · Prescription · Approval202302580
  • MFDS drugA-diance Duo Tab. 12.5/1000mg2023-08-30
    Drug · Prescription · Approval202302581
  • MFDS drugA-diance Duo Tab. 12.5/850mg2023-08-30
    Drug · Prescription · Approval202302582
  • MFDS drugAhngook Fexofenadine Tab. 60mg2023-08-23
    Drug · OTC · Notification202302507
  • MFDS drugCox2 Plus Tab.2023-08-10
    Drug · Prescription · Approval202302394
  • MFDS drugCarboxtella Eye drops2023-07-05
    Drug · OTC · Notification202302054
  • MFDS drugPevarozet Tab. 4/10mg2023-05-24
    Drug · Prescription · Approval202301661
  • MFDS drugPevarozet Tab. 2/10 mg2023-05-24
    Drug · Prescription · Approval202301662
  • MFDS drugAhn-gook edoxaban Tab. 30mg2023-04-19
    Drug · Prescription · Approval202301280
  • MFDS drugAhn-gook edoxaban Tab. 60mg2023-04-19
    Drug · Prescription · Approval202301281
  • MFDS drugAdapasita Duo Tab. 10/100mg2023-01-19
    Drug · Prescription · Approval202300306
  • MFDS drugA-dapa Tab. 5mg2022-12-02
    Drug · Prescription · Approval202204325
  • MFDS drugLevotitan Tab. 40/10mg2022-06-27
    Drug · Prescription · Approval202202672
  • MFDS drugA-dapa Tab. 10mg2022-05-23
    Drug · Prescription · Approval202202177
  • MFDS drugAtenel-M SR Tab. 10/500mg2022-05-23
    Drug · Prescription · Approval202202214
  • MFDS drugAtenel-M SR Tab. 10/750mg2022-05-23
    Drug · Prescription · Approval202202215
  • MFDS drugAtenel-M SR Tab. 20/1000mg2022-05-23
    Drug · Prescription · Approval202202216
  • MFDS drugA-sitamet XR Tab. 50/500mg2022-05-13
    Drug · Prescription · Approval202202027
  • MFDS drugA-sitamet XR Tab. 100/1000mg2022-05-13
    Drug · Prescription · Approval202202028
  • MFDS drugA-sitamet XR Tab. 50/1000mg2022-05-13
    Drug · Prescription · Approval202202029
  • MFDS drugSOFILIM EYE DROP2022-05-11
    Drug · OTC · Notification202201921
  • MFDS drugAhngooksugammadex Inj.2022-05-03
    Drug · Prescription · Approval202201789
  • MFDS drugPariem Duo tab. 5/850mg2022-04-04
    Drug · Prescription · Approval202201357
  • MFDS drugPariem Duo Tab. 50/500mg2022-04-04
    Drug · Prescription · Approval202201358
  • MFDS drugPariem Duo tab. 5/1000mg2022-04-04
    Drug · Prescription · Approval202201359
  • MFDS drugAtenel Tab. 20mg2022-01-25
    Drug · Prescription · Approval202200546
  • MFDS drugA-sitamet Tab. 50/850mg2022-01-11
    Drug · Prescription · Approval202200201
  • MFDS drugA-sitamet Tab. 50/1000mg2022-01-11
    Drug · Prescription · Approval202200202
  • MFDS drugA-sitamet Tab. 50/500mg2022-01-11
    Drug · Prescription · Approval202200203
  • MFDS drugAvusmet Tab. 50/500mg2021-10-22
    Drug · Prescription · Approval202107078
  • MFDS drugDobetella tab. 500mg2021-10-06
    Drug · Prescription · Approval202106756
  • MFDS drugSOS tab. 20/800mg2021-06-18
    Drug · Prescription · Approval202104743
  • MFDS drugPevaro Tab. 4mg2021-04-29
    Drug · Prescription · Approval202103521
  • MFDS drugAhngook rivaroxaban tab. 20 mgRevoked2021-04-22
    Drug · Prescription · Approval202103309
  • MFDS drugAhngook rivaroxaban tab. 15 mgRevoked2021-04-22
    Drug · Prescription · Approval202103310
  • MFDS drugAhngook rivaroxaban tab. 10 mgRevoked2021-04-22
    Drug · Prescription · Approval202103311
  • MFDS drugPevaro Tab. 1mg2021-03-31
    Drug · Prescription · Approval202102808
  • MFDS drugPariem tab. 10mgRevoked2021-03-05
    Drug · Prescription · Approval202102095
  • MFDS drugPariem tab. 25mgRevoked2021-03-05
    Drug · Prescription · Approval202102096
  • MFDS drugA-miga SR Tab. 50mg2021-02-18
    Drug · Prescription · Approval202101472
  • MFDS drugLipozet tab. 10/40 mg2021-01-08
    Drug · Prescription · Approval202100207
  • MFDS drugLipozet tab. 10/20 mg2021-01-08
    Drug · Prescription · Approval202100208
  • MFDS drugLipozet tab. 10/10 mg2021-01-08
    Drug · Prescription · Approval202100209
  • MFDS drugPrikalin Cap. 150mgRevoked2020-12-31
    Drug · Prescription · Approval202009394
  • MFDS drugAhngook Nafamostat 50mg Inj.Revoked2020-10-29
    Drug · Prescription · Approval202007401
  • MFDS drugAhngook Nafamostat 10mg Inj.Revoked2020-10-29
    Drug · Prescription · Approval202007402
  • MFDS drugRaperon Inj.2020-09-24
    Drug · Prescription · Notification202006593
  • MFDS drugCircaton PR tab. 2mg(Melatonin)2020-09-23
    Drug · Prescription · Approval202006576
  • MFDS drugPaglizin Tab. 10mgRevoked2020-07-23
    Drug · Prescription · Approval202005370
  • MFDS drugPaglizin Tab. 5mgRevoked2020-07-23
    Drug · Prescription · Approval202005371
  • MFDS drugRaperone 8 hours ER Tab. 650mgRevoked2020-07-16
    Drug · OTC · Approval202005157
  • MFDS drugRaperone Tab. 325mgRevoked2020-06-11
    Drug · OTC · Notification202004349
  • MFDS drugA-sita Tab. 25mg2020-05-29
    Drug · Prescription · Approval202004051
  • MFDS drugA-sita Tab. 50mg2020-05-29
    Drug · Prescription · Approval202004052
  • MFDS drugA-sita Tab. 100mg2020-05-29
    Drug · Prescription · Approval202004053
  • MFDS drugAhngook Duta Soft Cap. 0.5mgRevoked2020-05-29
    Drug · Prescription · Approval202004018
  • MFDS drugAhngook Telmi Tab. 40/12.5mgRevoked2020-05-29
    Drug · Prescription · Approval202004033
  • MFDS drugAhngook Telmi Tab. 80/12.5mgRevoked2020-05-29
    Drug · Prescription · Approval202004034
  • MFDS drugMosapra SR Tab. 15mg2020-05-28
    Drug · Prescription · Approval202003938
  • MFDS drugDonetia Tab. 10mg (Donepezil Hydrochloride Hydrate)2020-05-27
    Drug · Prescription · Approval202003900

Showing the 80 most recent of 342 records.

Clinical trials

data.go.kr

65 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 36 · Phase 1 18 · Phase 3 10 · Phase 2 1)

  • BioequivalenceAG-23032026-06-15

    1 trial site

  • BioequivalenceAG-23032026-06-15

    1 trial site

  • Phase 1AG23042025-09-19

    2 trial sites

  • BioequivalenceAG-24072025-09-01

    1 trial site

  • BioequivalenceAG2414T2025-05-09

    2 trial sites

  • Phase 3AG20012025-04-08

    10 trial sites

  • Phase 1AG23042025-03-31

    2 trial sites

  • Phase 1AG22032024-12-05

    1 trial site

  • Phase 3AG23042024-09-25

    16 trial sites

  • BioequivalenceAG22022024-04-08

    1 trial site

  • BioequivalenceAG21082023-05-08

    1 trial site

  • BioequivalenceAG16012023-03-16

    1 trial site

Show 53 more
  • Phase 3AGSAVI(AG-1705)2022-04-15

    30 trial sites

  • Bioequivalence클로펙트정(클로피도그렐황산염)2021-09-27

    1 trial site

  • Bioequivalence록시키드정(록시트로마이신)2021-05-14

    1 trial site

  • Bioequivalence라베톤정20밀리그램(라베프라졸나트륨)2021-04-21

    1 trial site

  • Bioequivalence토프리드정(이토프리드염산염)2021-04-09

    1 trial site

  • Bioequivalence안국록소프로펜나트륨정2021-04-09

    1 trial site

  • Phase 1AG18132020-12-17

    2 trial sites

  • Phase 3AGSAVI(AG-1705)2020-11-30

    19 trial sites

  • Bioequivalence클로펙트정(클로피도그렐황산염)2020-11-03

    1 trial site

  • Phase 1AGTZ2020-09-16

    1 trial site

  • Phase 3AGT, AGZ2020-05-20

    19 trial sites

  • Phase 1AG19012019-08-22

    2 trial sites

  • Phase 3AGS2019-08-06

    13 trial sites

  • Phase 1AG17052019-03-11

    1 trial site

  • Phase 3SDR18-P32018-11-07

    1 trial site

  • Phase 1AG17052018-05-04

    1 trial site

  • Bioequivalence칸토넬플러스발포정2018-03-19

    2 trial sites

  • Bioequivalence안국실로스타졸서방정200밀리그램2017-11-24

    2 trial sites

  • Bioequivalence안국실로스타졸서방정200밀리그램2017-11-24

    2 trial sites

  • Phase 1AG-16062017-06-21

    1 trial site

  • Bioequivalence안국빌다글립틴정2017-04-14

    1 trial site

  • Bioequivalence안국빌다메트정50/1000밀리그램2017-03-08

    2 trial sites

  • Phase 1AG15022017-02-01

    1 trial site

  • Bioequivalence안국리나듀오정2.5/1000밀리그램2017-01-26

    2 trial sites

  • Bioequivalence안국레바미피드정(레바미피드)2017-01-12

    1 trial site

  • Bioequivalence안국티카그렐러정90밀리그램2017-01-05

    1 trial site

  • Bioequivalence큐로스트정10밀리그램(몬테루카스트나트륨)2016-12-12

    1 trial site

  • Bioequivalence칸토넬플러스발포정2016-11-29

    2 trial sites

  • Bioequivalence안국오셀타미비르캡슐75밀리그램(오셀타미비르인산염)2016-11-23

    2 trial sites

  • Phase 1AG-16042016-11-10

    1 trial site

  • Bioequivalence안국리나글립틴정2016-11-02

    2 trial sites

  • Bioequivalence안국텔미암로정2016-02-26

    2 trial sites

  • Phase 1AG15022015-11-17

    1 trial site

  • Bioequivalence칸토넬플러스정2015-11-16

    2 trial sites

  • Bioequivalence푸로세틴캡슐(플루옥세틴염산염)[처방변경후]2015-11-04

    2 trial sites

  • Bioequivalence레보모스정 5/40 밀리그램 (변경후)2015-11-02

    1 trial site

  • Phase 1AG15022015-08-31

    1 trial site

  • Bioequivalence레보텐션정5밀리그램2015-05-20

    1 trial site

  • Phase 1LTP402015-04-03

    1 trial site

  • Bioequivalence타다라필오디프스20mg(산제)(가칭)(타다라필)2015-02-24

    2 trial sites

  • Bioequivalence리포액틴정40밀리그램(아토르바스타틴칼슘삼수화물)2014-12-23

    2 trial sites

  • Bioequivalence디스칸에프정2014-08-20

    1 trial site

  • Phase 1AGSAO302정2014-02-05

    1 trial site

  • Phase 1AGB_P12014-01-03

    1 trial site

  • Phase 3레토프라정10밀리그램2013-10-28

    10 trial sites

  • Phase 1레토프라정20밀리그램2013-04-15

    1 trial site

  • Bioequivalence디스칸정2013-04-03

    1 trial site

  • Phase 1레토프라정20밀리그램2013-02-15

    1 trial site

  • Bioequivalence푸로세틴캡슐(플루옥세틴염산염)2013-02-13
  • Phase 3AGR정(루파타딘푸마르산염)2012-07-13

    9 trial sites

  • Bioequivalence이베스딜정150밀리그램(이베사탄)2012-07-02

    2 trial sites

  • Phase 2NRF8032012-05-07

    7 trial sites

  • Phase 3AGP809정2012-03-20
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

HUONS CO., LTD.1 shared

KOSDAQ-listed pharmaceutical and healthcare company producing lidocaine anesthetics and the Kynix hyaluronic-acid eye-drop line.

BioPlus Co., Ltd1 shared

Founded in 2003 and KOSDAQ-listed in 2021, BioPlus develops HA-based bio medical devices and biopharmaceuticals using its proprietary MDM Technology platform.

Boditech Med Inc.1 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

PCL. Inc1 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

Daehan Nupharm Co.,Ltd.1 shared

KOSDAQ-listed pharmaceutical company producing a diverse, low-volume portfolio of metabolic disease drugs, wellness injections, and veterinary medicines.

Sugentech, Inc.1 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

Medy-Tox Inc.1 shared

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

Hironic Co.,Ltd1 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

PharmaResearch Co., Ltd.1 shared

KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.

YUNGJIN PHARM. CO., LTD1 shared

Founded in 1962 and listed on the KOSPI in 1973, Yungjin Pharm is a KT&G Group pharmaceutical affiliate exporting antibiotic injectables and APIs and operating a CMO business.

CELLUMED CO., LTD.1 shared

KOSDAQ-listed holding company making medical devices and biologics including bone graft rhBMP2 and knee implant TKR.

CAREGEN CO.,LTD.1 shared

CAREGEN develops peptide-based cosmeceuticals sold in 130 countries and ophthalmic drug candidates CG-P5 and CG-T1.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition